What is a stock summary page? Click here for an overview.
Business Description
Synairgen PLC
ISIN : GB00B0381Z20
Description
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.5 | |||||
| 3-Year EPS without NRI Growth Rate | 23.9 | |||||
| 3-Year FCF Growth Rate | 36.5 | |||||
| 3-Year Book Growth Rate | -47.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.23 | |||||
| 9-Day RSI | 53.07 | |||||
| 14-Day RSI | 47.72 | |||||
| 3-1 Month Momentum % | -51.61 | |||||
| 6-1 Month Momentum % | 69.68 | |||||
| 12-1 Month Momentum % | -42.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.76 | |||||
| Quick Ratio | 9.76 | |||||
| Cash Ratio | 7.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -54.39 | |||||
| ROA % | -47.67 | |||||
| ROIC % | -595.47 | |||||
| 3-Year ROIIC % | -47.83 | |||||
| ROC (Joel Greenblatt) % | -928.55 | |||||
| ROCE % | -68.24 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.11 | |||||
| Price-to-Tangible-Book | 0.35 | |||||
| EV-to-EBIT | -0.22 | |||||
| EV-to-Forward-EBIT | -0.01 | |||||
| EV-to-EBITDA | -0.22 | |||||
| EV-to-Forward-EBITDA | -0.01 | |||||
| EV-to-FCF | -0.28 | |||||
| Price-to-Net-Current-Asset-Value | 0.35 | |||||
| Price-to-Net-Cash | 0.35 | |||||
| Earnings Yield (Greenblatt) % | -458.24 | |||||
| FCF Yield % | -63.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synairgen PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.029 | ||
| Beta | 2.45 | ||
| 3-Year Sharpe Ratio | -0.51 | ||
| 3-Year Sortino Ratio | -0.67 | ||
| Volatility % | 161.1 | ||
| 14-Day RSI | 47.72 | ||
| 14-Day ATR (€) | 0.002014 | ||
| 20-Day SMA (€) | 0.005625 | ||
| 12-1 Month Momentum % | -42.64 | ||
| 52-Week Range (€) | 0.0005 - 0.0725 | ||
| Shares Outstanding (Mil) | 1,102.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synairgen PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synairgen PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synairgen PLC Frequently Asked Questions
What is Synairgen PLC(FRA:OMY)'s stock price today?
The current price of FRA:OMY is €0.01. The 52 week high of FRA:OMY is €0.07 and 52 week low is €0.00.
When is next earnings date of Synairgen PLC(FRA:OMY)?
The next earnings date of Synairgen PLC(FRA:OMY) is 2025-06-27 Est..
Does Synairgen PLC(FRA:OMY) pay dividends? If so, how much?
Synairgen PLC(FRA:OMY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers